<TEXT>&#2;<DATELINE>2016-09-30</DATELINE><TITLE>Use of recombinant virus technology to produce non-infectious, whole process controls for emerging viruses such as Ebola, Chikungunya, Dengue-2, Norovirus GII, MERS-CoV and Zika</TITLE><BODY>&#3;</BODY></TEXT>